Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Scott Berkowitz

Concepts (394)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rivaroxaban
115
2026
271
10.650
 Why?
Factor Xa Inhibitors
74
2026
194
5.710
 Why?
Aspirin
52
2026
406
4.440
 Why?
Anticoagulants
79
2026
748
4.420
 Why?
Stroke
69
2024
1271
4.070
 Why?
Peripheral Arterial Disease
32
2026
507
3.630
 Why?
Platelet Aggregation Inhibitors
51
2026
499
3.590
 Why?
Warfarin
42
2024
179
3.450
 Why?
Atrial Fibrillation
44
2024
558
3.250
 Why?
Hemorrhage
63
2026
822
2.830
 Why?
Intracranial Embolism
17
2021
34
2.320
 Why?
Morpholines
28
2024
130
2.230
 Why?
Thiophenes
27
2024
117
2.210
 Why?
Venous Thromboembolism
16
2022
328
2.030
 Why?
Embolism
17
2021
48
1.570
 Why?
Double-Blind Method
64
2026
2064
1.420
 Why?
Risk Adjustment
3
2020
85
1.380
 Why?
Arthroplasty, Replacement, Hip
9
2020
183
1.360
 Why?
Lower Extremity
16
2026
445
1.310
 Why?
Drug Monitoring
7
2021
401
1.250
 Why?
Endovascular Procedures
7
2026
390
1.170
 Why?
Myocardial Infarction
21
2024
1211
1.140
 Why?
Fibrinolytic Agents
12
2026
297
1.090
 Why?
Thrombosis
5
2026
400
1.060
 Why?
Vitamin K
15
2017
46
1.040
 Why?
Drug Therapy, Combination
33
2026
1044
1.000
 Why?
Coronary Artery Disease
10
2024
750
0.960
 Why?
Arthroplasty, Replacement, Knee
13
2020
375
0.910
 Why?
Aged
116
2026
26212
0.880
 Why?
Brain Ischemia
9
2022
359
0.870
 Why?
Treatment Outcome
76
2026
11793
0.870
 Why?
Enoxaparin
13
2020
68
0.810
 Why?
Heparin
15
2003
247
0.790
 Why?
Coronary Disease
12
2021
382
0.750
 Why?
Thromboembolism
8
2020
129
0.750
 Why?
Venous Thrombosis
12
2020
196
0.710
 Why?
Thrombolytic Therapy
7
2017
164
0.690
 Why?
Vascular Surgical Procedures
6
2026
343
0.690
 Why?
Brain Infarction
5
2021
23
0.670
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
9
2002
25
0.640
 Why?
Middle Aged
88
2026
36297
0.620
 Why?
Thrombocytopenia
11
2003
204
0.620
 Why?
Postoperative Complications
8
2024
2977
0.610
 Why?
Humans
177
2026
145750
0.600
 Why?
Male
122
2026
72992
0.600
 Why?
Ischemia
8
2024
422
0.580
 Why?
Female
119
2026
79025
0.560
 Why?
Blood Coagulation
10
2026
274
0.540
 Why?
Administration, Oral
25
2021
867
0.530
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
261
0.530
 Why?
Risk Assessment
19
2024
3752
0.500
 Why?
Risk Factors
41
2026
10916
0.500
 Why?
Angioplasty, Balloon, Coronary
8
2003
156
0.450
 Why?
Cardiovascular Diseases
9
2021
2190
0.430
 Why?
Immunoglobulin Fab Fragments
7
2002
56
0.430
 Why?
Prothrombin Time
5
2020
33
0.430
 Why?
Pulmonary Embolism
9
2020
241
0.420
 Why?
Dose-Response Relationship, Drug
18
2021
2028
0.410
 Why?
Blood Transfusion
4
2014
409
0.400
 Why?
Drug Administration Schedule
16
2021
782
0.360
 Why?
Biomarkers, Pharmacological
3
2020
26
0.360
 Why?
Secondary Prevention
8
2025
251
0.350
 Why?
Cerebral Hemorrhage
3
2021
125
0.340
 Why?
Aged, 80 and over
25
2026
8346
0.320
 Why?
Surgical Wound Infection
1
2014
329
0.320
 Why?
Azetidines
6
2005
45
0.300
 Why?
Angina, Unstable
5
2003
83
0.300
 Why?
Recurrence
11
2021
1139
0.290
 Why?
Plaque, Atherosclerotic
2
2020
61
0.280
 Why?
Heart Valve Prosthesis Implantation
2
2001
198
0.280
 Why?
Antibodies, Monoclonal
9
2002
1505
0.270
 Why?
Time Factors
18
2026
7133
0.270
 Why?
Randomized Controlled Trials as Topic
13
2024
1751
0.260
 Why?
Models, Statistical
3
2020
672
0.260
 Why?
Prognosis
6
2021
4329
0.250
 Why?
Vascular Diseases
2
2021
252
0.250
 Why?
Incidence
11
2021
2933
0.240
 Why?
Gastrointestinal Hemorrhage
2
2019
138
0.240
 Why?
Platelet Aggregation
3
2002
99
0.230
 Why?
Atherosclerosis
2
2019
409
0.230
 Why?
Kaplan-Meier Estimate
9
2021
971
0.220
 Why?
Hemostasis
1
2026
98
0.220
 Why?
Aortic Valve Insufficiency
2
2016
43
0.220
 Why?
Mitral Valve Insufficiency
2
2016
68
0.210
 Why?
Follow-Up Studies
14
2020
5428
0.210
 Why?
International Normalized Ratio
5
2018
55
0.210
 Why?
Diabetes Mellitus
5
2021
1101
0.200
 Why?
Internationality
6
2021
156
0.200
 Why?
Proportional Hazards Models
9
2021
1330
0.200
 Why?
von Willebrand Factor
5
1993
85
0.200
 Why?
Anti-Arrhythmia Agents
2
2015
144
0.200
 Why?
Clinical Trials as Topic
7
2026
1062
0.200
 Why?
Arteries
2
2022
261
0.200
 Why?
Intention to Treat Analysis
7
2021
79
0.200
 Why?
Chemoprevention
2
2020
92
0.190
 Why?
Myocardial Ischemia
3
2000
285
0.190
 Why?
Antifibrinolytic Agents
2
2014
64
0.190
 Why?
Platelet Function Tests
2
2002
35
0.190
 Why?
Postoperative Care
2
2003
286
0.190
 Why?
Acute Coronary Syndrome
2
2019
297
0.180
 Why?
Withholding Treatment
2
2021
80
0.180
 Why?
Drug Carriers
1
2003
136
0.180
 Why?
Renal Insufficiency
2
2021
172
0.180
 Why?
Electrocardiography
4
2001
668
0.180
 Why?
Carotid Artery Diseases
2
2019
70
0.180
 Why?
Echocardiography, Transesophageal
2
2019
132
0.180
 Why?
Multimorbidity
1
2022
65
0.170
 Why?
Drug-Eluting Stents
1
2021
88
0.170
 Why?
Drug Substitution
3
2021
63
0.160
 Why?
Heart Valves
1
2001
44
0.160
 Why?
Therapeutic Index
1
2020
3
0.160
 Why?
Intracranial Arteriosclerosis
1
2020
8
0.160
 Why?
Paclitaxel
1
2021
259
0.160
 Why?
Troponin T
1
2020
63
0.160
 Why?
Thrombin
4
2014
172
0.150
 Why?
Intracranial Hemorrhages
4
2019
106
0.150
 Why?
Clinical Trials, Phase III as Topic
5
2019
116
0.150
 Why?
Thrombophlebitis
2
1997
12
0.140
 Why?
Tyrosine
1
2000
217
0.140
 Why?
Partial Thromboplastin Time
5
2014
53
0.140
 Why?
Comorbidity
6
2021
1662
0.140
 Why?
Point-of-Care Systems
2
2014
189
0.140
 Why?
Foramen Ovale, Patent
1
2018
11
0.140
 Why?
Kidney
2
2017
1498
0.140
 Why?
Emigrants and Immigrants
1
2021
158
0.140
 Why?
Cardiomegaly
1
2020
174
0.140
 Why?
Peptide Fragments
5
2003
696
0.140
 Why?
Ischemic Attack, Transient
2
2018
71
0.140
 Why?
Coronary Thrombosis
3
2016
25
0.140
 Why?
Polypharmacy
2
2016
94
0.130
 Why?
Heart Diseases
1
2021
341
0.130
 Why?
Antigens
1
1999
348
0.130
 Why?
Heart Failure
6
2021
2326
0.130
 Why?
Prospective Studies
12
2021
8075
0.130
 Why?
Brain
2
2020
2969
0.120
 Why?
Surgery, Oral
1
1996
7
0.120
 Why?
Aorta, Thoracic
1
2019
286
0.120
 Why?
Orthodontic Appliances
1
1996
13
0.120
 Why?
Drug Discovery
2
2015
153
0.120
 Why?
Body Mass Index
3
2021
2447
0.120
 Why?
Calcium Channel Blockers
1
2017
166
0.120
 Why?
Prodrugs
4
2005
52
0.120
 Why?
Angioplasty, Balloon
1
1997
94
0.120
 Why?
Antibodies, Monoclonal, Humanized
2
2020
992
0.120
 Why?
Overweight
1
2021
614
0.120
 Why?
Cleft Lip
1
1996
73
0.110
 Why?
Prevalence
5
2021
2874
0.110
 Why?
Neoplasms
3
2020
2913
0.110
 Why?
Cleft Palate
1
1996
91
0.110
 Why?
Age Factors
5
2026
3346
0.110
 Why?
Multivariate Analysis
6
2016
1547
0.110
 Why?
Digoxin
1
2015
27
0.110
 Why?
Limb Salvage
2
2026
73
0.110
 Why?
Factor X
1
2014
26
0.110
 Why?
Prothrombin
1
2014
25
0.110
 Why?
Factor VII
1
2014
24
0.110
 Why?
Factor IX
1
2014
49
0.100
 Why?
Severity of Illness Index
6
2021
2933
0.100
 Why?
Cognitive Dysfunction
1
2020
468
0.100
 Why?
Amiodarone
1
2014
31
0.100
 Why?
Cognition Disorders
1
2018
544
0.100
 Why?
Blood Coagulation Factors
1
2014
71
0.100
 Why?
Cardiovascular Agents
1
2015
166
0.100
 Why?
Biomarkers
3
2020
4302
0.100
 Why?
Defibrillators, Implantable
1
2017
387
0.100
 Why?
Recombinant Proteins
4
2015
1368
0.100
 Why?
Models, Biological
2
2019
1764
0.100
 Why?
Arthroplasty, Replacement, Ankle
1
2012
11
0.090
 Why?
Mortality
3
2021
380
0.090
 Why?
Hematoma
1
2013
63
0.090
 Why?
Adult
17
2020
40867
0.090
 Why?
Elective Surgical Procedures
1
2014
203
0.090
 Why?
Hirudins
2
2003
53
0.090
 Why?
Sex Factors
4
2021
2110
0.090
 Why?
von Willebrand Diseases
2
1990
28
0.090
 Why?
Survival Rate
5
2020
2094
0.090
 Why?
Depression
1
2021
1557
0.090
 Why?
Heparin, Low-Molecular-Weight
2
2005
37
0.090
 Why?
Delivery of Health Care, Integrated
1
2014
303
0.080
 Why?
Percutaneous Coronary Intervention
1
2016
549
0.080
 Why?
Continuity of Patient Care
1
2013
297
0.080
 Why?
Acute Disease
6
2021
1036
0.080
 Why?
Peptides
4
2002
998
0.080
 Why?
Latin America
2
2021
96
0.080
 Why?
Predictive Value of Tests
4
2021
2123
0.080
 Why?
Benzylamines
6
2005
44
0.080
 Why?
Factor Xa
3
2015
36
0.080
 Why?
Retrospective Studies
10
2018
17322
0.080
 Why?
Quality of Life
1
2022
3210
0.070
 Why?
Chemical and Drug Induced Liver Injury
1
2011
138
0.070
 Why?
Mental Health Services
1
2014
475
0.070
 Why?
Tissue Plasminogen Activator
3
2022
248
0.070
 Why?
Single-Blind Method
2
2020
318
0.070
 Why?
Sialic Acids
1
1988
8
0.070
 Why?
Platelet Count
3
1998
94
0.070
 Why?
Obesity, Morbid
1
2013
293
0.070
 Why?
Multicenter Studies as Topic
3
2018
413
0.070
 Why?
Pancreatic Elastase
1
1988
53
0.070
 Why?
Hospitalization
2
2016
2460
0.070
 Why?
Calpain
1
1988
61
0.070
 Why?
Injections, Subcutaneous
4
2010
170
0.070
 Why?
Magnetic Resonance Imaging
4
2021
3915
0.070
 Why?
Peptide Hydrolases
1
1988
105
0.070
 Why?
Logistic Models
4
2021
2139
0.070
 Why?
Platelet Transfusion
2
1999
77
0.060
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2021
346
0.060
 Why?
Hypertension
1
2016
1276
0.060
 Why?
Obesity
1
2021
3118
0.060
 Why?
Drug Approval
2
2015
93
0.060
 Why?
International Cooperation
2
2018
197
0.060
 Why?
Magnetic Resonance Angiography
2
2019
251
0.060
 Why?
United States Food and Drug Administration
2
2015
208
0.060
 Why?
Infant
4
2026
10089
0.060
 Why?
Child
6
2026
22738
0.060
 Why?
Chronic Disease
2
2025
1810
0.060
 Why?
Cohort Studies
3
2022
6032
0.060
 Why?
Drug Combinations
2
2019
396
0.060
 Why?
Infusions, Intravenous
2
1998
428
0.060
 Why?
Europe
2
2019
421
0.060
 Why?
Child, Preschool
4
2026
11866
0.060
 Why?
Preoperative Care
2
2020
380
0.060
 Why?
Adolescent
8
2020
22569
0.060
 Why?
Infant, Newborn
3
2026
6464
0.060
 Why?
Combined Modality Therapy
2
2020
1270
0.060
 Why?
Purinergic P2Y Receptor Antagonists
2
2018
71
0.050
 Why?
Creatinine
2
2017
515
0.050
 Why?
Forecasting
2
2013
390
0.050
 Why?
Pharmacokinetics
1
2003
33
0.050
 Why?
Safety
3
2000
358
0.050
 Why?
Caprylates
1
2003
19
0.050
 Why?
Body Weight
2
1998
972
0.050
 Why?
Angiography
1
2024
208
0.050
 Why?
United States
5
2019
16122
0.050
 Why?
Cause of Death
2
2016
471
0.050
 Why?
Myocardial Revascularization
2
2000
85
0.050
 Why?
Numbers Needed To Treat
1
2021
7
0.040
 Why?
Mobility Limitation
1
2022
67
0.040
 Why?
Injections, Intravenous
2
2000
197
0.040
 Why?
Pipecolic Acids
1
2001
26
0.040
 Why?
Hirudin Therapy
1
2000
2
0.040
 Why?
Intermittent Claudication
1
2022
122
0.040
 Why?
Frailty
1
2024
205
0.040
 Why?
Antineoplastic Agents, Phytogenic
1
2021
178
0.040
 Why?
Antithrombins
1
2000
71
0.040
 Why?
Patient Care
1
2021
120
0.040
 Why?
Streptokinase
2
1997
9
0.040
 Why?
Heart Valve Diseases
1
2001
151
0.040
 Why?
Acetates
1
2000
78
0.040
 Why?
Patient Safety
2
2013
356
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
75
0.040
 Why?
Stents
2
2002
564
0.040
 Why?
Animals
6
2026
38100
0.040
 Why?
Cerebral Angiography
1
2019
119
0.040
 Why?
Drug Dosage Calculations
1
2019
27
0.040
 Why?
Heart Atria
1
2020
141
0.040
 Why?
Monitoring, Physiologic
1
2001
289
0.040
 Why?
MEDLINE
1
2018
20
0.040
 Why?
Diagnostic Tests, Routine
1
2019
107
0.030
 Why?
Sex Distribution
2
2015
388
0.030
 Why?
Antibody Formation
1
1999
288
0.030
 Why?
Arginine
2
2015
264
0.030
 Why?
Disease-Free Survival
1
2020
770
0.030
 Why?
Placebos
1
1998
193
0.030
 Why?
Australia
1
2019
291
0.030
 Why?
Dermatan Sulfate
1
1997
4
0.030
 Why?
Blood Pressure
2
2016
1782
0.030
 Why?
Computed Tomography Angiography
1
2019
146
0.030
 Why?
Pyridones
1
2020
209
0.030
 Why?
Global Health
1
2021
403
0.030
 Why?
Alanine Transaminase
2
2011
151
0.030
 Why?
Catheters, Indwelling
1
1998
96
0.030
 Why?
Chondroitin Sulfates
1
1997
35
0.030
 Why?
Statistics, Nonparametric
1
2018
428
0.030
 Why?
Coronary Artery Bypass
1
2000
268
0.030
 Why?
Hemodilution
1
1997
11
0.030
 Why?
Health Status Disparities
1
2021
321
0.030
 Why?
Diltiazem
1
2017
17
0.030
 Why?
Ligands
1
1999
668
0.030
 Why?
Blood Transfusion, Autologous
1
1997
18
0.030
 Why?
Verapamil
1
2017
37
0.030
 Why?
Walking
1
2022
542
0.030
 Why?
Hip Prosthesis
1
1997
42
0.030
 Why?
Recombinant Fusion Proteins
1
2000
666
0.030
 Why?
Postoperative Period
2
2013
351
0.030
 Why?
Gingivoplasty
1
1996
1
0.030
 Why?
Alveoloplasty
1
1996
2
0.030
 Why?
Lip
1
1996
23
0.030
 Why?
Morbidity
1
2017
322
0.030
 Why?
Maxillofacial Development
1
1996
20
0.030
 Why?
Kidney Function Tests
1
2017
156
0.030
 Why?
Knee Prosthesis
1
1997
28
0.030
 Why?
Phlebography
2
2009
41
0.030
 Why?
Survival Analysis
1
2000
1378
0.030
 Why?
Glomerular Filtration Rate
1
2020
765
0.030
 Why?
China
1
2017
273
0.030
 Why?
Bone Transplantation
1
1996
89
0.030
 Why?
Pyrazoles
1
2020
517
0.030
 Why?
Thrombophilia
1
2016
89
0.030
 Why?
Geography
1
2016
187
0.030
 Why?
Cardiopulmonary Bypass
1
1997
219
0.030
 Why?
Federal Government
1
2015
23
0.030
 Why?
Depressive Disorder
1
2018
374
0.030
 Why?
Blood Platelets
1
1998
379
0.030
 Why?
Clinical Decision-Making
1
2019
364
0.030
 Why?
Death, Sudden
1
2015
26
0.030
 Why?
Government Regulation
1
2015
39
0.030
 Why?
Anxiety Disorders
1
2018
371
0.030
 Why?
Drug Industry
1
2015
49
0.030
 Why?
Baltimore
1
2014
72
0.030
 Why?
Communication
1
2021
976
0.030
 Why?
Healthy Volunteers
1
2014
219
0.020
 Why?
Area Under Curve
1
2014
332
0.020
 Why?
Congresses as Topic
1
2015
224
0.020
 Why?
Risk
1
2016
923
0.020
 Why?
Leukemia, Promyelocytic, Acute
1
1993
8
0.020
 Why?
North America
1
2014
303
0.020
 Why?
Endopeptidases
1
1993
80
0.020
 Why?
Aortic Valve Stenosis
1
2016
256
0.020
 Why?
Hemarthrosis
1
2012
22
0.020
 Why?
Neurotransmitter Agents
1
2013
84
0.020
 Why?
Macromolecular Substances
2
1993
216
0.020
 Why?
Piperazines
1
2015
375
0.020
 Why?
Plasma
1
2014
223
0.020
 Why?
Comparative Effectiveness Research
1
2013
169
0.020
 Why?
Evidence-Based Medicine
1
2016
740
0.020
 Why?
Pancreatitis
1
1993
146
0.020
 Why?
Clinical Protocols
1
2013
280
0.020
 Why?
Algorithms
1
1999
1850
0.020
 Why?
Validation Studies as Topic
1
2011
23
0.020
 Why?
Acenocoumarol
1
2010
1
0.020
 Why?
Heart Rate
1
2015
856
0.020
 Why?
Liver Function Tests
1
2011
105
0.020
 Why?
Bilirubin
1
2011
99
0.020
 Why?
Liver Cirrhosis
1
1993
287
0.020
 Why?
Adverse Drug Reaction Reporting Systems
1
2011
81
0.020
 Why?
Alkaline Phosphatase
1
2011
144
0.020
 Why?
Drug Design
1
2011
175
0.020
 Why?
Syndrome
2
2002
381
0.020
 Why?
Cognition
1
2018
1271
0.020
 Why?
Patient Selection
1
2014
739
0.020
 Why?
Tomography, X-Ray Computed
1
2019
2770
0.020
 Why?
Biomedical Research
1
2015
719
0.020
 Why?
Coronary Angiography
2
2001
328
0.020
 Why?
Amino Acid Sequence
2
1990
2131
0.020
 Why?
Molecular Targeted Therapy
1
2011
440
0.020
 Why?
Structure-Activity Relationship
1
1988
563
0.020
 Why?
Risk Reduction Behavior
1
2009
217
0.020
 Why?
Molecular Structure
1
1988
487
0.020
 Why?
Immunoblotting
3
1993
295
0.020
 Why?
Registries
1
2016
2410
0.020
 Why?
Research Design
1
2013
1139
0.020
 Why?
In Vitro Techniques
1
1988
1049
0.020
 Why?
Epitopes
1
1988
473
0.020
 Why?
Analysis of Variance
1
2009
1300
0.010
 Why?
Blotting, Western
1
1988
1184
0.010
 Why?
Leukemia, Myeloid, Acute
1
1993
688
0.010
 Why?
Models, Molecular
1
2011
1599
0.010
 Why?
Cross-Sectional Studies
1
2016
5921
0.010
 Why?
Sensitivity and Specificity
1
2009
2000
0.010
 Why?
Hemostatics
1
2003
64
0.010
 Why?
Random Allocation
1
2003
365
0.010
 Why?
Fibrinolysin
2
1993
19
0.010
 Why?
Mice
1
2000
18357
0.010
 Why?
Drug Resistance
1
2002
145
0.010
 Why?
Statistics as Topic
1
2002
283
0.010
 Why?
Purpura
1
2001
18
0.010
 Why?
Blood Coagulation Tests
1
2001
72
0.010
 Why?
Wound Healing
1
2003
355
0.010
 Why?
Angina Pectoris
1
2000
76
0.010
 Why?
Exanthema
1
2001
86
0.010
 Why?
Diarrhea
1
2001
193
0.010
 Why?
Confidence Intervals
1
2000
330
0.010
 Why?
Probability
1
2000
308
0.010
 Why?
Age Distribution
1
2000
404
0.010
 Why?
Mutation
1
1990
4090
0.010
 Why?
Equipment Design
1
2001
525
0.010
 Why?
Odds Ratio
1
2000
1083
0.010
 Why?
Young Adult
1
2014
14250
0.010
 Why?
Hematocrit
1
1997
108
0.010
 Why?
Sulfonamides
1
2001
583
0.010
 Why?
Pain
1
2001
791
0.010
 Why?
Health Care Costs
1
1998
425
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
1993
331
0.010
 Why?
Disease Progression
1
2000
2865
0.010
 Why?
Ristocetin
1
1992
1
0.010
 Why?
Length of Stay
1
1998
1350
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
1992
25
0.010
 Why?
Reference Values
1
1993
798
0.010
 Why?
Oligonucleotide Probes
1
1990
48
0.010
 Why?
Polymerase Chain Reaction
1
1990
1043
0.000
 Why?
Base Sequence
1
1990
2171
0.000
 Why?
Amino Acids
1
1990
519
0.000
 Why?
Molecular Sequence Data
1
1990
2883
0.000
 Why?
DNA
1
1990
1437
0.000
 Why?
Berkowitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (394) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)